Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Dr. Sanja Tomovska

Achievements

—Founded and serves as CEO of Quant Biomarkers AG.
—Works in the field of quantitative biomarkers and precision health.
—More than 20 years of experience in pharmaceutical and biotechnology leadership, including work with Novartis, Roche, and Abbott.

Dr. Sanja Tomovska

Founder & CEO

Quant Biomarkers AG

About

Dr. Sanja Tomovska is a pharmaceutical executive, scientist, and biotechnology entrepreneur with more than 20 years of experience across the pharmaceutical, biotechnology, and diagnostics industries. Based in Switzerland, she is the Founder and CEO of Quant Biomarkers AG, a precision diagnostics company focused on developing biomarker-based solutions for earlier disease detection, risk assessment, and personalised healthcare.

Dr. Tomovska holds a PhD in Molecular Biology from the University of Basel, Switzerland, specialising in cancer research and biomarkers in cancer diagnostics. Her scientific background is complemented by executive business education at INSEAD and additional business studies at Columbia Business School. Her early research focused on molecular and genetic changes associated with tumour development and progression, including published work on urinary bladder cancer.

Throughout her pharmaceutical career, Dr. Tomovska has held strategic and leadership responsibilities at major international companies, including Novartis, Roche, and Abbott. Her experience spans research and development, clinical and medical affairs, pharmaceutical portfolio strategy, mergers and acquisitions, product lifecycle management, commercialisation, and market access. She has also been involved in business transformation initiatives and the development of strategies to expand access to innovative medicines across international markets.

As CEO of Quant Biomarkers, Dr. Tomovska leads the company's development of precision diagnostic technologies, including biomarker panels designed to support earlier detection and better understanding of chronic diseases. The company's work includes kidney-health diagnostics and risk assessment for cardio-kidney-metabolic conditions. She is also involved in the longevity and preventive-health sector through her role as Co-founder and General Manager of Humansa Suisse, contributing to initiatives that connect scientific innovation with personalised health and longevity services.

  • In addition to her executive responsibilities, Dr. Tomovska participates in international biotechnology and healthcare forums, sharing perspectives on precision medicine, diagnostics, pharmaceutical innovation, and the future of longevity healthcare. She is also involved in entrepreneurship and innovation initiatives in Switzerland.

Events & Activities

Abu Dhabi Future Health Summit 2026
Oct 20, 2026
In-Person

Abu Dhabi Future Health Summit 2026

dmg events

  • CME Credits
  • Abu Dhabi National Exhibition Centre (ADNEC), Abu Dhabi
Oct 20, 2026
In-Person

Abu Dhabi Future Health Summit 2026

Free

The Abu Dhabi Future Health Summit 2026 is a premier global platform uniting researchers, policymakers, and healthcare specialists to drive transformative health innovation and accelerate collaboration for longer, healthier lives.

dmg events

  • 3 Days
  • Abu Dhabi National Exhibition Centre (ADNEC), Abu Dhabi
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
Dr. Sanja Tomovska — Founder & CEO | MedArena